Beijing, China

Na Xing


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):

Title: Na Xing: Innovator in Pharmaceutical Chemistry

Introduction

Na Xing is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pegylated artesunate derivatives. His research focuses on enhancing the efficacy and stability of pharmaceutical compounds.

Latest Patents

Na Xing holds a patent for a pegylated artesunate derivative, which is a pharmaceutical composition with notable applications. This pegylated artesunate derivative is represented by a specific general formula and exhibits activity comparable to that of artesunate. It also boasts increased water solubility and stability, along with an extended half-life in vivo. This innovation has the potential to improve treatment outcomes for various medical conditions.

Career Highlights

Throughout his career, Na Xing has worked with reputable organizations, including KPC Pharmaceuticals, Inc. and the Institute of Pharmacology and Toxicology at the Academy of Military Medical Science, PLA China. His experience in these institutions has allowed him to develop and refine his expertise in pharmaceutical research and development.

Collaborations

Na Xing has collaborated with notable colleagues in his field, including Sicheng Li and Qingbin Meng. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Na Xing's contributions to pharmaceutical chemistry, particularly through his pegylated artesunate derivative, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…